Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Receivables - Net of $413000.0 for Q1 2026, down 99.97% year-over-year from $1.3 billion in Q1 2025, and little changed quarter-over-quarter from $413000.0 in Q4 2025.
Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Receivables - Net history runs 10 years deep, the most recent figure standing at $413000.0 for Q1 2026.
- In Q1 2026, Receivables - Net fell 99.97% year-over-year to $413000.0; the TTM figure through Mar 2026 stood at $413000.0 (down 99.97% YoY), while the FY2025 annual figure was $413000.0, down 7.61% from the prior year.
- Receivables - Net for Q1 2026 stood at $413000.0, roughly flat from $413000.0 in the prior quarter.
- The five-year high for Receivables - Net was $1.4 billion in Q3 2025, with the low at $413000.0 in Q4 2025.
- The 5-year median for Receivables - Net is $1.1 billion (2022), against an average of $800.4 million.
- The sharpest annual moves came in 2024 and 2026: Receivables - Net jumped 111.97% in 2024, then slumped 99.97% in 2026.
- Amneal Pharmaceuticals' Receivables - Net stood at $486000.0 in 2022, then jumped by 245477.16% to $1.2 billion in 2023, then plunged by 99.96% to $447000.0 in 2024, then dropped by 7.61% to $413000.0 in 2025, then changed by 0.0% to $413000.0 in 2026.
- Business Quant data shows AMRX's Receivables - Net at $413000.0 in Q1 2026, $413000.0 in Q4 2025, and $1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.07 Bn | 2.15 Bn |
| 3 | Zoetis | 32.51 Bn | 30.83 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 19.01 Bn | 18.13 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.76 Bn | 5.63 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Bn |
| Jun 30, 2026 | 1.61 Bn |
| Mar 31, 2026 | 413,000.00 |
| Mar 31, 2026 | 413,000.00 |
| Dec 31, 2025 | 413,000.00 |
| Dec 31, 2025 | 413,000.00 |
| Sep 30, 2025 | 1.44 Bn |
| Sep 30, 2025 | 1.44 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 447,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Sep 30, 2024 | 1.21 Bn |
| Sep 30, 2024 | 1.21 Bn |
| Jun 30, 2024 | 1.24 Bn |
| Jun 30, 2024 | 1.24 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |